retatrutide obesity triple hormone receptor agonist Retatrutide: A Shaping the Future of Metabolic Care Retatrutide—A Game Changer in Obesity

Real talk on peptides Peptides are chains of amino acids with a remarkably low risk profile compared to many pharmaceuticals

Months 2 through 3 This is where things get interesting

Pharmacokinetics: approximate terminal half-life 6 days, Cmax at 40-48 hours post-injection, steady-state in 4-5 weeks

Response options included yes, significantly

We can discuss semaglutide, tirzepatide, oral medications, hormone optimization, thyroid concerns, nutrition, exercise, and other factors affecting weight

Serotonin Syndrome Considerations Patients sometimes ask whether combining an SSRI with Ozempic raises serotonin syndrome risk